Science that speaks
for itself.
Cited turns peer-reviewed research into questions you can actually engage with. Real claims. Real citations. No hype, no dumbing down — just the evidence, explained the way a knowledgeable friend would explain it.
Start with GLP-1How it works
Read the statement
A real scientific claim — could be about benefits, risks, or how to use the drug.
Pick True or False
Commit to your best guess. You won't know until after you answer whether the verdict is True, False, or Not Enough Data Yet.
Learn the science
See the verdict with a plain-language explanation and links to the actual studies behind it.
How we think about evidence
Not all scientific claims are equal. A single anecdotal report is very different from a 17,000-person randomized trial. Every answer on Cited shows a confidence level so you can see how solid the science really is.
Large Phase III RCTs, FDA-approved, replicated across multiple trials.
Phase II–III trials or strong observational data. Likely real, more confirmation underway.
Phase II, mechanistic evidence, or large observational studies. Promising but not yet confirmed.
Case reports, forum data, or theoretical mechanisms. Interesting but not yet studied properly.
When a claim falls in the 40–70% confidence zone, the answer is Not Enough Data Yet — and you get the point regardless of what you guessed. Because that uncertainty is itself the scientific truth worth knowing.
Topics
GLP-1 Receptor Agonists
Ozempic · Wegovy · Mounjaro · Zepbound
The most talked-about drugs of the decade. 50 questions covering real risks, real benefits, and the practical stuff your pharmacist wishes you knew.
Metformin
Glucophage · Extended Release
The world's most prescribed diabetes drug — and one with some of the most surprising emerging science, including the TAME aging trial. Coming next.